<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab10">
 <label>Table 28.10</label>
 <caption>
  <p>Prediction of drug efficacy</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Protease inhibitor</th>
    <th>Sensitive below</th>
    <th>Resistant above</th>
    <th>Sensitivity (%)</th>
    <th>Specificity (%)</th>
    <th>Kappa
     <sup>2</sup>
    </th>
    <th>
     <italic>p</italic> value
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Amprenavir</td>
    <td>0.7</td>
    <td>1.4</td>
    <td>86.7</td>
    <td>100</td>
    <td>0.907</td>
    <td>&lt;0.0001</td>
   </tr>
   <tr>
    <td>Indinavir</td>
    <td>0.6</td>
    <td>1.5</td>
    <td>94.1</td>
    <td>100</td>
    <td>0.958</td>
    <td>&lt;0.0001</td>
   </tr>
   <tr>
    <td>Nelfinavir</td>
    <td>0.7</td>
    <td>1.0</td>
    <td>60.6</td>
    <td>96.8</td>
    <td>0.567</td>
    <td>&lt;0.0001</td>
   </tr>
   <tr>
    <td>Ritonavir</td>
    <td>0.7</td>
    <td>1.4</td>
    <td>100</td>
    <td>84.1</td>
    <td>0.754</td>
    <td>&lt;0.0001</td>
   </tr>
   <tr>
    <td>Saquinavir</td>
    <td>0.6</td>
    <td>1.1</td>
    <td>68.4</td>
    <td>100</td>
    <td>0.752</td>
    <td>&lt;0.0001</td>
   </tr>
   <tr>
    <td>Lopinavir</td>
    <td>0.3</td>
    <td>0.7</td>
    <td>100</td>
    <td>83</td>
    <td>0.755</td>
    <td>&lt;0.0001</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Comparison of computational drug resistance phenotype with laboratory phenotyping ∆
   <italic>E</italic> bind cuttoff (kcal/mol)
  </p>
  <p>ViroLogic PhenoSense (ViroLogic, 
   <ext-link ext-link-type="uri" xlink:href="http://www.virologic.com" xmlns:xlink="http://www.w3.org/1999/xlink">http:/www.virologic.com</ext-link>)
  </p>
  <p>Kappa is measure of inter-assay agreement: kappa &gt; 0.75, excellent agreement; 0.4 &lt; kappa &lt; 0.75, good agreement; kappa &lt; 0.4, poor agreement</p>
  <p>Nevirapine and tipranavir (Boehringer Ingelheim, 
   <ext-link ext-link-type="uri" xlink:href="http://www.boehringer-ingelheim.com" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.boehringer-ingelheim.com</ext-link>)
  </p>
  <p>Saquinavir (Roche, 
   <ext-link ext-link-type="uri" xlink:href="http://www.roche.com" xmlns:xlink="http://www.w3.org/1999/xlink">http//www.roche.com</ext-link>)
  </p>
  <p>Amprenavir (Glaxo Wellcome, 
   <ext-link ext-link-type="uri" xlink:href="http://www.gsk.com" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.gsk.com</ext-link>)
  </p>
  <p>Indinavir (Merck, 
   <ext-link ext-link-type="uri" xlink:href="http://www.merck.com" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.merck.com</ext-link>)
  </p>
  <p>Nelfinavir (Pfizer, 
   <ext-link ext-link-type="uri" xlink:href="http://www.pfizer.com" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.pfizer.com</ext-link>) (Lopinavir)
  </p>
  <p>Ritonavir (Abbot, 
   <ext-link ext-link-type="uri" xlink:href="http://www.abbot.com" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.abbot.com</ext-link>)
  </p>
 </table-wrap-foot>
</table-wrap>
